Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.59 |
| ▸ | RAB9A | P51151 | 4/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.54 |
| ▸ | EGFR | P00533 | 1/20 | 0.49 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | FABP7 | O15540 | 2/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL517354 | 0.80 | MAOA (0.56) | NPC1RAB9ACYP2C19KMT2AMEN1 | |
| SCHEMBL26885232 | 0.76 | NPC1 (0.81) | NPC1RAB9ACYP2C19CYP1A2CYP3A4 | |
| SCHEMBL30184438 | 0.76 | NPC1 (1.00) | NPC1RAB9ACYP2C19CYP1A2CYP3A4 | |
| SCHEMBL4642544 | 0.76 | NPC1 (1.00) | NPC1RAB9ACYP2C19CYP1A2CYP3A4 | |
| SCHEMBL7539037 | 0.75 | NPC1 (0.78) | NPC1RAB9ACYP2C19CYP1A2CYP3A4 | |
| SCHEMBL3659724 | 0.75 | RAB9A (0.84) | NPC1RAB9ACYP2C19CYP1A2CYP3A4 | |
| SCHEMBL3679744 | 0.74 | RAB9A (0.76) | NPC1RAB9ACYP2C19CYP1A2CYP3A4 | |
| SCHEMBL30735621 | 0.74 | RAB9A (0.76) | NPC1RAB9ACYP2C19CYP1A2CYP3A4 | |
| SCHEMBL29124091 | 0.74 | NPC1 (0.76) | NPC1RAB9ACYP2C19CYP1A2CYP3A4 | |
| SCHEMBL27447692 | 0.74 | NPC1 (0.76) | NPC1RAB9ACYP2C19CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2392458-B1 | POLYPROPYLENE RESIN MOLDED ARTICLE | NEW JAPAN CHEM CO LTD (JP) | 2018-03-14 | — | — | EP | disclosed |
| US-9023921-B2 | Method for inhibiting crystal growth rate of amide compound and method for producing molded article of polyolefin-based resin | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2015-05-05 | — | — | US | disclosed |
| US-8592071-B2 | Laminated porous film and separator for battery | MITSUBISHI PLASTICS, INC. (JP) | 2013-11-26 | — | — | US | disclosed |
| EP-2431415-A1 | METHOD FOR CONTROLLING CRYSTAL GROWTH RATE OF AMIDE COMPOUND AND METHOD FOR PRODUCING MOLDED ARTICLE OF POLYOLEFIN-BASED RESIN | New Japan Chemical Co., Ltd. (JP) | 2012-03-21 | — | — | EP | disclosed |
| US-20120035304-A1 | METHOD FOR INHIBITING CRYSTAL GROWTH RATE OF AMIDE COMPOUND AND METHOD FOR PRODUCING MOLDED ARTICLE OF POLYOLEFIN-BASED RESIN | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20120028006-A1 | POLYPROPYLENE RESIN MOLDED ARTICLE | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2012-02-02 | — | — | US | disclosed |
| EP-2392458-A2 | POLYPROPYLENE RESIN MOLDED ARTICLE | New Japan Chemical Co., Ltd. (JP) | 2011-12-07 | — | — | EP | disclosed |
| US-20110212358-A1 | LAMINATED POROUS FILM AND SEPARATOR FOR BATTERY | MITSUBISHI PLASTICS, INC. (JP) | 2011-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035304-A1 | METHOD FOR INHIBITING CRYSTAL GROWTH RATE OF AMIDE COMPOUND AND METHOD FOR PRODUCING MOLDED ARTICLE OF POLYOLEFIN-BASED RESIN | MNAT1, RFT1, RTF1 | NPC1 2313/4885RAB9A 4496/4885CYP2C19 3570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.